Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines
Pierre Gourdy(Université Toulouse III - Paul Sabatier), Paul Valensi(Hôpital Jean-Verdier), François Schiele(Hôpital Saint-Jacques), Samy Hadjadj(Université de Poitiers), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Serge Kownator
Cited by 32
Related Papers
Sex differences in metabolic regulation and diabetes susceptibility
|Diabetologia|2019|876
Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry
|European Heart Journal|2010|557
Acute Myocardial Infarction
|Circulation|2017|534
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
|The Lancet Diabetes & Endocrinology|2017|295
Effect of a diabetic environment in utero on predisposition to type 2 diabetes
|The Lancet|2003|286